Ruflo, Jameberluke K.
HRN: 23-04-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/18/2023
05/25/2023
IVTT
730mg
Q8
URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes